Chittorgarh.com Logo
Loading...
Apr 27, 2021 - May 10, 2021

Aarti Drugs Limited Buyback (Aarti Drugs Buyback) Detail

Aarti Drugs Limited is one of the leading pharma companies in India .The company manufactures over 40 products comprising of bulk actives, key intermediates, and specialty chemicals. Its product portfolio includes anti-biotic, anti-protozoal, anti-inflammatory, anti-fungal, anti-diabetic, cardio-protectant, vitamins, anti-arthritis, sedatives therapeutic groups that help in lifesaving and lifestyle related diseases .


The Company has nine manufacturing locations located at Tarapur (Maharashtra) and two manufacturing locations located at Sarigam (Gujarat), most of them being GMP certified . The company exports its products to over 100 countrie s worldwide.

Aarti Drugs Buyback Detail

Issue PeriodApr 27, 2021 - May 10, 2021
Security NameAarti Drugs Limited
Issue TypeTender Offer
Issue Size (Shares)0.06 Crores
Issue Size (Amount)₹60.00 Crores
Buyback Price₹1000 per share
Face Value₹10 per share
Listing AtBSE, NSE

Aarti Drugs Buyback Issue Timetable

Offer Opens OnApr 27, 2021
Offer Closes OnMay 10, 2021
Record DateApr 1, 2021
Last Date for receipt of Tender FormsMay 12, 2021
Finalisation of Buyback AcceptanceMay 19, 2021
Last Date for settlment of bidsMay 20, 2021
Last Date for Extinguishment of SharesMay 27, 2021

Buyback Ratio

Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 8 Equity Shares out of every 569 paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders 5 Equity Shares out of every 851 paid-up Equity Shares held on the Record Date.

Company Financials

Summary of financial Information (consolidated)
Particulars For the year/period ended (Rs. in Millions)
31-Mar-20 31-Mar-19 31-Mar-18
Total Income 18,075.71 15,671.17 12,636.18
Profit After Tax 1,413.99 897.52 823.07
Net Worth 6,467.45 5,373.09 4,502.79

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2021 694.95 625 658.87
Jan-2021 755.5 670.05 710.03
Dec-2021 812 645 741.25

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2021 695 628 658.75
Jan-2021 756 670 710.11
Dec-2021 811 645.65 741.17

Necessity of the Issue

The Buyback aims to :
i) Service the equity more efficiently.
ii) Return surplus cash to the shareholders.
ii) Improve Return on Equity
iii) Improve earnings per share and thus increase the shareholder's value in the long-term.

Aarti Drugs Buyback Documents

Aarti Drugs Buyback Rating

8
4.3
Rating:Rated 4.3 stars
Vote Here ...

Aarti Drugs Buyback Reviews

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Aarti Drugs Limited
Plot No. – N-198,
M.I.D.C., Village - Pamtermbhi
Taluka & Dist. Palghar - 401 506

Phone: +91 22 2404 8199
Email: investorrelations@aartidrugs.com
Website: https://www.aartidrugs.co.in/

Aarti Drugs Buyback Registrar

  1. Link Intime India Private Ltd
       Link Intime India Private Ltd
       C 101, 247 Park, L.B.S.Marg,
       Vikhroli (West), Mumbai - 400083

    Phone: +91-22-4918 6270
    Email: aartidrugs.buyback2021@linkintime.co.in
    Website: http://www.linkintime.co.in

Aarti Drugs Buyback Manager

Lead Manager(s)

  1. Inga Ventures Pvt Ltd

Registered Broker

  1. Ghalla Bhansali Stock Brokers Private Limited
    Email: pareshv@ghallabhansali.com

Find Aarti Drugs Buyback Latest Update

Aarti Drugs Buyback FAQs

The Aarti Drugs Buyback opens on Apr 27, 2021, and closes on May 10, 2021.

The Aarti Drugs Buyback is a Tender Offer.

Aarti Drugs Buyback Schedule

Buyback Opening DateApr 27, 2021
Buyback Closing DateMay 10, 2021
Last Date for receipt of Tender FormsMay 12, 2021
Finalisation of Buyback AcceptanceMay 19, 2021
Last Date for settlment of bidsMay 20, 2021
Last Date for Extinguishment of SharesMay 27, 2021

The Aarti Drugs Buyback is being offered at Rs ₹1000 per share per equity share.

Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 8 Equity Shares out of every 569 paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders 5 Equity Shares out of every 851 paid-up Equity Shares held on the Record Date.

The record date for the Aarti Drugs Buyback is Apr 1, 2021.

The issue size of Aarti Drugs Buyback is of 0.06 Crores equity shares at ₹1000 per share aggregating upto ₹60.00 Crores.

The Buyback aims to :
i) Service the equity more efficiently.
ii) Return surplus cash to the shareholders.
ii) Improve Return on Equity
iii) Improve earnings per share and thus increase the shareholder's value in the long-term.

All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.

The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.

The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.

The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.

The Aarti Drugs Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.


Comments

Add a public comment...